Overview
John Meletis practices in Athens, Greece. Mr. Meletis is rated as an Advanced expert by MediFind in the treatment of Hyperferritinemia-Cataract Syndrome. His top areas of expertise are Hodgkin Lymphoma, Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), Hyperferritinemia-Cataract Syndrome, B-Cell Lymphoma, and Bone Marrow Transplant.
His clinical research consists of co-authoring 19 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Hodgkin LymphomaMr. Meletis isAdvanced. Learn about Hodgkin Lymphoma.
- Hyperferritinemia-Cataract SyndromeMr. Meletis isAdvanced. Learn about Hyperferritinemia-Cataract Syndrome.
- Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
- Experienced
- Adult Immune ThrombocytopeniaMr. Meletis isExperienced. Learn about Adult Immune Thrombocytopenia.
- B-Cell LymphomaMr. Meletis isExperienced. Learn about B-Cell Lymphoma.
- Bone Marrow TransplantMr. Meletis isExperienced. Learn about Bone Marrow Transplant.
- Diffuse Large B-Cell Lymphoma (DLBCL)Mr. Meletis isExperienced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Immune Thrombocytopenic Purpura (ITP)Mr. Meletis isExperienced. Learn about Immune Thrombocytopenic Purpura (ITP).
- Marginal Zone Lymphoma (MZL)Mr. Meletis isExperienced. Learn about Marginal Zone Lymphoma (MZL).